1. Home
  2. VRME vs NCEL Comparison

VRME vs NCEL Comparison

Compare VRME & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$1.14

Market Cap

8.4M

Sector

Technology

ML Signal

HOLD

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$2.42

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VRME
NCEL
Founded
1999
2008
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
10.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VRME
NCEL
Price
$1.14
$2.42
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
10.6M
198.7K
Earning Date
03-05-2026
12-01-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,669,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$1.89
52 Week High
$3.57
$7.64

Technical Indicators

Market Signals
Indicator
VRME
NCEL
Relative Strength Index (RSI) 58.99 N/A
Support Level $0.94 N/A
Resistance Level $1.51 N/A
Average True Range (ATR) 0.18 0.00
MACD 0.04 0.00
Stochastic Oscillator 59.20 0.00

Price Performance

Historical Comparison
VRME
NCEL

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Share on Social Networks: